000 | 01973 a2200505 4500 | ||
---|---|---|---|
005 | 20250516031556.0 | ||
264 | 0 | _c20110624 | |
008 | 201106s 0 0 eng d | ||
022 | _a1091-6490 | ||
024 | 7 |
_a10.1073/pnas.1100652108 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, Erinna F | |
245 | 0 | 0 |
_aDiscovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cApr 2011 |
||
300 |
_a6999-7003 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 |
_aHelminth Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNitrophenols _xpharmacology |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSchistosoma japonicum _xgenetics |
650 | 0 | 4 |
_aSchistosoma mansoni _xgenetics |
650 | 0 | 4 |
_aSchistosomiasis japonica _xdrug therapy |
650 | 0 | 4 |
_aSchistosomiasis mansoni _xdrug therapy |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
700 | 1 | _aClarke, Oliver B | |
700 | 1 | _aEvangelista, Marco | |
700 | 1 | _aFeng, Zhiping | |
700 | 1 | _aSpeed, Terence P | |
700 | 1 | _aTchoubrieva, Elissaveta B | |
700 | 1 | _aStrasser, Andreas | |
700 | 1 | _aKalinna, Bernd H | |
700 | 1 | _aColman, Peter M | |
700 | 1 | _aFairlie, W Douglas | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 108 _gno. 17 _gp. 6999-7003 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.1100652108 _zAvailable from publisher's website |
999 |
_c20713947 _d20713947 |